Clinical Trials Browser

Active not recruiting × Blood Specimen Collection × 90 days × Clear all

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1 Active not recruiting

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT02867033 2026-03-18

ALTITUDES

Phase NA Active not recruiting

Desmoid Tumors

NCT04454528 2026-03-10

BreastVAX

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT02531607 2026-02-05

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03424915 2026-02-04

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active not recruiting

Breast Neoplasms

NCT05415358 2026-02-03

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Phase 1/2 Active not recruiting

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT03875690 2026-01-20

CORTIFRENCH

Phase 3 Active not recruiting

Elective Surgery for Any Digestive Cancer

NCT03465618 2026-01-07

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Phase 1 Active not recruiting

Brain Neoplasms, Pituitary Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Phase 1 Active not recruiting

Endometrial Neoplasms